Daniel K. Spiegelman
Sits on 5 boards. Overboarded · 5 public boards Last updated September 28, 2026
Time on boards
- Boards served
- 5
- Current seats
- 5
- Board service
- 13 years
- Director since
- 2023
13 years of board service in total across 5 boards, counting each seat separately. Longest: Spruce Biosciences Inc., 3 years.
Spruce Biosciences Inc.
Director
Myriad Genetics Inc.
Director
Kyverna Therapeutics Inc.
Director
vTv Therapeutics Inc.
Director
Maze Therapeutics Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 4, 2024 | Myriad Genetics Inc. | Open-market sale | −3,788 | $22.05 | $83,525 |
| Jun 3, 2024 | Myriad Genetics Inc. | Open-market sale | −3,788 | $22.04 | $83,488 |
| Jun 2, 2023 | Myriad Genetics Inc. | Open-market sale | −8,638 | $23.01 | $198,760 |
| Jun 1, 2023 | Myriad Genetics Inc. | Grant or award | +15,151 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.